[The survival indices of patients with stage IV gastric cancer treated by polyplatilen].
The survival indices of patients suffering gastric cancer stage IV in application of cytostatic preparation polyplatilen were studied up. The most expedient mode of treatment was suggested the conduction of no less than 2 courses of monochemotherapy. As a result, one year had survived (22.53 +/- 4.68)% patients, three years--(7.54 +/- 3.16)%, five years--(4.43 +/- 2.46)%.
Iatsenko
L D
LD
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D018736:DNA Adducts / Q000008:administration & dosage / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology
D000970:Antineoplastic Agents; D018736:DNA Adducts; C057270:cisplatin-DNA adduct; D002945:Cisplatin